Alternative splicing is commonly altered in cancer and as such has become a target for the designing of new drugs. While many drugs have been designed to target either the new isoforms that favour cancer development or proteins involved in the splicing pathway, AI can improve this by helping ...
"Our vision is to take advantage of the decreasing cost of DNA sequencing and to harness the power of AI to understand cancer cell differences and what they mean for the individual patient's treatment. Through our research, we were able to identify cell-specific...
Volume 24 | June 2024 | 357–358 | 357 nature reviews cancerhttps://doi.org/10.1038/s41568-024-00685-8CommentGuardrails for the use of generalist AI in cancer careStephen Gilbert & Jakob Nikolas KatherArtif i cial narrow intelligence models, trained for specif i c intended purposes, ha...
on behalf of the clinically authoritative Response Assessment in Neuro-Oncology cooperative group, which is a collaboration of international experts who develop standardized criteria for evaluating treatment response in clinical trials for brain cancer....
根据第一段的内容“Docters can use Al to show your risk of lung cancer (肺癌) with a single CT scan (扫描检查). (医生可以利用人工智能通过一次CT扫描来显示你患肺癌的风险)”和第三段中的“Researchers recently developed Sybil, an Al model that can tell someone’s future lung cancer risk in ...
AI are significant... JP Bergerat - 《Presse Médicale》 被引量: 2发表: 2007年 USE OF FPT INHIBITORS AND AT LEAST TWO ANTINEOPLASTIC AGENTS IN THE TREATMENT OF CANCER. Disclosed is a use of an FPT inhibitor for the manufacture of a medicament for the treatment of cancer (e.g., non ...
Also, the treatment protocol given in conforming with TORCH-predicted origins resulted in an overall survival of 27 months as against 17 months for those who were administrated discordant treatment. The study highlighted the AI system's potential as a valuable ancillary tool in clinical practice, al...
After receiving a five-year grant from the National Cancer Institute (NCI), researchers from Rensselaer Polytechnic Institute (RPI) and Albany Medical Collegeaim to determine the capabilities of artificial intelligence (AI)in improving breast cancer treatment. ...
A translational research team led by the National University of Singapore (NUS) has harnessed CURATE.AI, a powerful artificial intelligence (AI) platform, to treat a patient with advanced cancer, completely halting disease progression. This new developme
The widespread use of artificial intelligence (AI) in medical decision-making tools has led to an update of the TRIPOD guidelines for reporting clinical prediction models. The new TRIPOD+AI guidelines are launched in the BMJ today.